title: Interlukin-6 receptor inhibitor tocilizumab: a new treatment option in rheumatoid arthritis?
authors.forename: Jeremiah
authors.initials: J
authors.lastname: Johnson
authors.forename: Michael Y
authors.initials: MY
authors.lastname: Wang
mesh_terms: D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D019947:Receptors, Interleukin-6 / Q000037:antagonists & inhibitors* / Q000502:physiology; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D019947:Receptors, Interleukin-6; C502936:tocilizumab